Open AccessIncidence and radiologic‐pathological features of lung cancer in idiopathic pulmonary fibrosis
Author(s) -
Liu Yan,
Zhu Min,
Geng Jing,
Ban Chengjun,
Zhang Shu,
Chen Wenhui,
Ren Yanhong,
He Xuan,
Chen Wang,
Dai Huaping
Publication year - 2018
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.12732
Subject(s) - medicine , lung cancer , idiopathic pulmonary fibrosis , adenocarcinoma , lung , cancer , population , gastroenterology , pathology , environmental health
Objective To investigate the incidence and risk factors of lung cancer in patients with idiopathic pulmonary fibrosis (IPF), and to learn the clinical, imaging and pathological features and of lung cancer in IPF. Methods The study population included consecutive 268 IPF patients. Of them, 46 patients had pathologically or cytologically proven lung cancer. The demographic, clinical, HRCT and pathological features in patients with IPF and lung cancer were analysed and compared with the patients with IPF alone. Results Of 268 IPF patients, 46 patients were diagnosed as IPF with lung cancer, accounted for 17.16%. 45.65% were adenocarcinoma. Lung cancer located mostly in the peripheral area and lower lobes of lungs consistent with IPF affected area. Old age and heavy smoking were risk factors of lung cancer developing in IPF. Chest pain and haemoptysis were more frequent in IPF patients with lung cancer than without lung cancer ( P = .000). Nodular or mass shadows were found only in IPF patients with lung cancer ( P = .000). The levels of CEA and CA125 in IPF patients were much higher in IPF patients with lung cancer ( P ≤ .001). The median survival time was 36.2 ± 22.7 months in IPF patients, longer than 6.9 ± 3.3 months in IPF patients with lung cancer ( P < .001). Conclusions Lung cancer frequently develops in patients with IPF, which is mainly adenocarcinoma, located in IPF affected area. Chest pain and haemoptysis are potential indicative of lung cancer developing in patients with IPF as atypical nodes or masses located in the peripheral areas and lower lobes on chest HRCT.